Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
UMass Chan Medical SchoolResidency, Internal Medicine, 2006 - 2009
Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2005 - 2006
Punjab Medical CollegeClass of 2003
Certifications & Licensure
TX State Medical License 2012 - 2026
CA State Medical License 2019 - 2025
PA State Medical License 2022 - 2024
LA State Medical License 2020 - 2022- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsPromising Therapeutic Targets for Recurrent/Metastatic Anaplastic Thyroid Cancer.Abdelrahman Sherif Abdalla, Mobeen Rahman, Saad A Khan
Current Treatment Options in Oncology. 2024-07-01 - 11 citationsRadiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase ...Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein
The Lancet. Oncology. 2023-02-01 - 152 citationsTumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2,...Vivek Subbiah, Jürgen Wolf, Bhavana Konda, Hyunseok Kang, Alexander Spira
The Lancet. Oncology. 2022-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
